-transparent.png){kind=logo}
We have investigated whether a hydrophilic photosensitizer, chlorin e6Na (Ce6Na), can sensitize cells to ionizing radiation. When V79-1 cells were pretreated with Ce6Na for 2 hr before receiving a dose of 2-14 Gy of irradiation, the cells became sensitive to X-irradiation. The sensitizing effect of Ce6Na depended on the dose of Ce6Na. The sensitizing effect also depended on the length of the treatment period before X-irradiation up to 4 hr, but not on the length of a treatment period after X-irradiation. Intracellular concentrations of Ce6Na were increased linearly after incubation with Ce6Na for periods of up to 4 h. The dose-modifying factor calculated from the survival curve was 1.25.
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
November 2021,
Radiation research,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
November 1975,
International journal of radiation biology and related studies in physics, chemistry, and medicine,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
March 2012,
Free radical research,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
March 1962,
Radiation research,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
August 2003,
International journal of radiation biology,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
April 2020,
Toxicology research,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
August 2007,
Cancer letters,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
March 1953,
Cancer,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
November 2003,
Molecular cancer therapeutics,
Y Hosoi, and
M Kawamura, and
T Ido, and
Y Takai, and
K Ishii, and
K Nemoto, and
T Ono, and
S Kimura, and
K Sakamoto
January 2020,
Frontiers in oncology,
